MedPath

Intracardiac T-wave Alternans and Ischemia

Completed
Conditions
Ischemia
Registration Number
NCT00669552
Lead Sponsor
Columbia University
Brief Summary

T-wave alternans is a test that looks at microvolt changes in the T-wave on a beat to beat basis. The presence or absence of such changes has been shown to predict or exclude future arrhythmic events. The mechanism of T-wave alternans is unclear, but may relate to calcium metabolism in the heart, and may be affected by conditions such as ischemia or heart failure.

The purpose of this study is to determine whether T-wave alternans, as measured through the lead of an implantable defibrillator, is produced by acute ischemia induced by occlusion during percutaneous coronary interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • patient with CAD undergoing PCI with appropriate Medtronic implantable defibrillator.
Exclusion Criteria
  • non-elective procedure
  • non-qualifying defibrillator type.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Subjects With Positive T Wave Studies During a Coronary InterventionDuring the coronary intervention, upto 2 hours

Positive T wave alternans is determined by a proprietary program using ECG recordings during a stress test. The result is reported as positive, negative, or indeterminate.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Columbia University Medical Center

🇺🇸

New York, New York, United States

Columbia University Medical Center
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.